Analysis of Mitochondrial Function in Cell Membranes as Indicator of Tissue Vulnerability to Drugs in Humans

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Drug side effects frequently lead to clinical trial withdrawal.
• Reactive oxygen species (ROS) formation is implicated in many drug toxicities, often via cellular respiration interference.
• Early detection of ROS formation is crucial for optimizing drug discovery and development.

Purpose of the Study:

• To evaluate superoxide formation induced by various drugs with diverse pharmacological properties.
• To assess the utility of cell membrane microarrays for detecting drug-induced mitochondrial toxicity.
• To identify potential biomarkers for predicting adverse drug reactions in preclinical stages.

Main Methods:

• Superoxide formation was measured in isolated bovine heart membranes and human tissue-derived cell membrane microarrays.
• Specific inhibitors of the mitochondrial electron transport chain were used as controls.
• Drugs evaluated included those with antidepressant, antipsychotic, anticholinergic, narcotic, and analgesic properties.

Main Results:

• Fluphenazine and PB28 demonstrated direct action on mitochondrial complex I, similar to rotenone but less potent.
• Nefazodone, a withdrawn drug, induced the highest superoxide formation in human liver cell membranes.
• The cell membrane microarray technology showed potential in identifying drugs with mitochondrial hepatotoxic effects.

Conclusions:

• The evaluated technology can anticipate adverse drug effects in preclinical phases.
• Assessing drug-induced superoxide formation is a valuable strategy for drug safety assessment.
• This approach aids in the optimization of pharmacological research by identifying potential toxic liabilities early.